A Unique Case of Autoimmune Retinopathy Associated with Anti-Alpha-Enolase Antibodies

Background. We report a case of autoimmune retinopathy associated with anti-alpha-enolase antibodies with unique manifestations. Methods. A case report. Results. A 30-year-old male experienced recurrent, primarily peripheral visual field disturbances and minimal photopsia, with interval symptom reso...

Full description

Bibliographic Details
Main Authors: Paul A. Kurz, Rachel E. Reem, Daryl E. Kurz, Richard G. Weleber
Format: Article
Language:English
Published: Hindawi Limited 2011-01-01
Series:Case Reports in Ophthalmological Medicine
Online Access:http://dx.doi.org/10.1155/2011/371324
id doaj-7ded2e40f851435cb65bc5b65436b391
record_format Article
spelling doaj-7ded2e40f851435cb65bc5b65436b3912020-11-24T20:57:45ZengHindawi LimitedCase Reports in Ophthalmological Medicine2090-67222090-67302011-01-01201110.1155/2011/371324371324A Unique Case of Autoimmune Retinopathy Associated with Anti-Alpha-Enolase AntibodiesPaul A. Kurz0Rachel E. Reem1Daryl E. Kurz2Richard G. Weleber3Dayton VA Medical Center, Dayton, OH 45428, USAHavener Eye Institute, The Ohio State University, 915 Olentangy River Road, Columbus, OH 43212, USARoudebush VA Medical Center, Indianapolis, IN 46202, USACasey Eye Institute, Oregon Health & Science University, 3375 SW Terwilliger Boulevard, Portland, OR 97239-4197, USABackground. We report a case of autoimmune retinopathy associated with anti-alpha-enolase antibodies with unique manifestations. Methods. A case report. Results. A 30-year-old male experienced recurrent, primarily peripheral visual field disturbances and minimal photopsia, with interval symptom resolution. Fundus changes subsequently developed in areas corresponding to the previous visual field symptoms. Electroretinogram showed bilaterally symmetric abnormalities of light-adapted responses and suggested loss of photoreceptor function. Only anti-alpha-enolase antibodies were detected on Western blot. Our patient noted cutaneous symptoms at the time of both episodes of visual symptoms, but not in the interim. Biomicroscopy revealed subtle small reddish spots in areas of the peripheral retina corresponding to the areas of the patient’s visual field where he noted symptoms. To our knowledge these reddish spots have not been reported in autoimmune retinopathy and may clinically support in vitro and in vivo evidence that anti-alpha-enolase antibodies may target photoreceptors. Conclusions. Our patient demonstrates some unique features adding to the known characteristics of autoimmune retinopathy associated with anti-alpha-enolase antibodies. As more cases are reported, further understanding of the features and pathophysiology of this rare condition will hopefully be elucidated.http://dx.doi.org/10.1155/2011/371324
collection DOAJ
language English
format Article
sources DOAJ
author Paul A. Kurz
Rachel E. Reem
Daryl E. Kurz
Richard G. Weleber
spellingShingle Paul A. Kurz
Rachel E. Reem
Daryl E. Kurz
Richard G. Weleber
A Unique Case of Autoimmune Retinopathy Associated with Anti-Alpha-Enolase Antibodies
Case Reports in Ophthalmological Medicine
author_facet Paul A. Kurz
Rachel E. Reem
Daryl E. Kurz
Richard G. Weleber
author_sort Paul A. Kurz
title A Unique Case of Autoimmune Retinopathy Associated with Anti-Alpha-Enolase Antibodies
title_short A Unique Case of Autoimmune Retinopathy Associated with Anti-Alpha-Enolase Antibodies
title_full A Unique Case of Autoimmune Retinopathy Associated with Anti-Alpha-Enolase Antibodies
title_fullStr A Unique Case of Autoimmune Retinopathy Associated with Anti-Alpha-Enolase Antibodies
title_full_unstemmed A Unique Case of Autoimmune Retinopathy Associated with Anti-Alpha-Enolase Antibodies
title_sort unique case of autoimmune retinopathy associated with anti-alpha-enolase antibodies
publisher Hindawi Limited
series Case Reports in Ophthalmological Medicine
issn 2090-6722
2090-6730
publishDate 2011-01-01
description Background. We report a case of autoimmune retinopathy associated with anti-alpha-enolase antibodies with unique manifestations. Methods. A case report. Results. A 30-year-old male experienced recurrent, primarily peripheral visual field disturbances and minimal photopsia, with interval symptom resolution. Fundus changes subsequently developed in areas corresponding to the previous visual field symptoms. Electroretinogram showed bilaterally symmetric abnormalities of light-adapted responses and suggested loss of photoreceptor function. Only anti-alpha-enolase antibodies were detected on Western blot. Our patient noted cutaneous symptoms at the time of both episodes of visual symptoms, but not in the interim. Biomicroscopy revealed subtle small reddish spots in areas of the peripheral retina corresponding to the areas of the patient’s visual field where he noted symptoms. To our knowledge these reddish spots have not been reported in autoimmune retinopathy and may clinically support in vitro and in vivo evidence that anti-alpha-enolase antibodies may target photoreceptors. Conclusions. Our patient demonstrates some unique features adding to the known characteristics of autoimmune retinopathy associated with anti-alpha-enolase antibodies. As more cases are reported, further understanding of the features and pathophysiology of this rare condition will hopefully be elucidated.
url http://dx.doi.org/10.1155/2011/371324
work_keys_str_mv AT paulakurz auniquecaseofautoimmuneretinopathyassociatedwithantialphaenolaseantibodies
AT rachelereem auniquecaseofautoimmuneretinopathyassociatedwithantialphaenolaseantibodies
AT darylekurz auniquecaseofautoimmuneretinopathyassociatedwithantialphaenolaseantibodies
AT richardgweleber auniquecaseofautoimmuneretinopathyassociatedwithantialphaenolaseantibodies
AT paulakurz uniquecaseofautoimmuneretinopathyassociatedwithantialphaenolaseantibodies
AT rachelereem uniquecaseofautoimmuneretinopathyassociatedwithantialphaenolaseantibodies
AT darylekurz uniquecaseofautoimmuneretinopathyassociatedwithantialphaenolaseantibodies
AT richardgweleber uniquecaseofautoimmuneretinopathyassociatedwithantialphaenolaseantibodies
_version_ 1716787633534795776